In patients with middle cerebral artery occlusion (MCAO), serum EPO levels peaked 2.6-fold at day 7 after MCAO and remained elevated until day 30 post stroke (Ehrenreich et al., 2002). The gene discussed is EPO; the disease is stroke disorder.